Neoantigen-primed DC Vaccines Therapy for Refractory Lung Cancer

Clinical trial NCT03871205 · UNKNOWN

Trial details

NCT number: NCT03871205
Sponsor: Shenzhen People's Hospital
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Carcinoma, Non-Small Cell Lung Carcinoma, Small Cell Lung

Start date: 2019-04-01
Primary completion: 2020-06-30
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.